Born in 2013, with offices in Barcelona, Spain, HiTT is an international market access consultancy with a payer perspective. Our main activities revolve around advising and working together with institutions, research centers and private companies in the healthcare sector, wishing to develop and implement innovative projects. HiTT’s team is dedicated to health and healthcare, we accumulate more than 30 years’ experience in implementing and producing solutions in both the field of research and healthcare.
Fostering innovation that contributes to the sustainability of the healthcare ecosystem.
Encourage public-private collaboration to improve health and deliver valuable healthcare.
Involvement, Commitment and Professionalism.
We focus our efforts and dedication to support companies, start-ups and institutions in the following areas of work
Expert consulting to support business strategic decission-making and investments in the healthcare sector.
MARKET ACCESS STRATEGIES
Trusted independent advisors with a payer’s perspective.
Striving to create innovative solutions for healthcare challenges.
NEWS & EVENTS
Add a subtitle in Customizer, "Latest news section"
The immune system is amazingly complex, precise and synchronised to deliver effective responses against most health insults. Likewise, medical challenges need to be faced with a multidisciplinary, coordinated and target-specific approach.
At the intersection of two current topics; the COVID-19 pandemic and the global outcry regarding repeat incidences of racial discrimination and violence in the United States, lies the recent finding that the novel SARS-CoV-2 virus has hit African American and Latino communities harder than others.
In 2016, AQuAS (Catalan Agency for Health Quality and Evaluation), defined indicators used to evaluate the clinical and healthcare quality as a measurement instrument used to evaluate or measure specific aspects of the quality of care.
Before 2020 there was Good consensus that the new epidemic was obesity. Increasing prevalence, increasing incidence, limited available first line effective treatments, clear social gradient
The R&D response to the SARS-CoV-2 outbreak has been massive, promoted by unprecedented funding to support innovative solutions to fight the COVID-19 pandemic.
Clinical research is essential in contemporary medicine. It is a source of knowledge to improve healthcare, as it which is based on evidence. It helps to evaluate new drugs and , therapies. It is a a necessary step to test new assets but also to develop and gather advice from the best key opinion leaders.
Across all industries 9 out of 10 start-ups will fail. This staggering statistic doesn’t exactly inspire confidence. In healthcare the failure-rate may not be as detrimental but remains cause for concern. Which begs the question: why do so many start-ups fail?
HiTT celebrates that Barcelona Activa recognizes Qbeast with an award for the best project of high technological impact and Hospital Vall d’Hebron obtains more than 1M€ benefit from the exploitation of a patent license.